Harmony Biosciences
HRMY
HRMY
290 hedge funds and large institutions have $1.3B invested in Harmony Biosciences in 2025 Q3 according to their latest regulatory filings, with 46 funds opening new positions, 113 increasing their positions, 86 reducing their positions, and 27 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
6.88% less ownership
Funds ownership: 89.24% → 82.36% (-6.9%)
20% less capital invested
Capital invested by funds: $1.62B → $1.3B (-$316M)
Holders
290
Holding in Top 10
3
Calls
$30.8M
Puts
$8.95M
Top Buyers
| 1 | +$10.7M | |
| 2 | +$9.44M | |
| 3 | +$7.22M | |
| 4 |
BA
Bridgewater Associates
Westport,
Connecticut
|
+$5.83M |
| 5 |
Renaissance Technologies
New York
|
+$5.72M |
Top Sellers
| 1 | -$147M | |
| 2 | -$25.5M | |
| 3 | -$23.2M | |
| 4 |
NFGH
Nan Fung Group Holdings
Kai Tak,
Hong Kong
|
-$9.41M |
| 5 |
Macquarie Group
Sydney, NSW 2000,
Australia
|
-$4.02M |
